CRLconf 0.85

lamotrigine — CRL

$ETON · Eton Pharmaceuticals, Inc.

Event date

Date TBD

Sponsor runway

cash-flow +

$19.7M liquid

Evidence

“Eton was notified that its partner, Azurity Pharmaceuticals, received a Complete Response Letter from the U.S. Food and Drug Administration ("FDA") regarding the New Drug Application for the lamotrigine product candidate.”

Source: 8-K filed 2022-05-27View on EDGAR ↗0001493152-22-015359

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

1 insider · 0 buys · 0 sells

Exercise

2026-04-21

RIEDEL NORBERT G

Director

12,500 @ $7.31$91K

Exercise

2026-04-21

RIEDEL NORBERT G

Director

19,655 @ $8.61$169K

Date	Insider	Action	Shares	Price	Value
2026-04-21	RIEDEL NORBERT GDirector	Exercise	12,500	$7.31	$91K
2026-04-21	RIEDEL NORBERT GDirector	Exercise	19,655	$8.61	$169K

← All catalysts for $ETON